Clinical trial
Effect of Midazolam as Premedication in Patients Undergoing Breast Conservation Study
NCT07184125 is registered in ClinicalTrials.gov with Shaukat Khanum Memorial Cancer Hospital & Research Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Midazolam as Premedication in Patients Undergoing Breast Conservation Study
- Lead sponsor
- Shaukat Khanum Memorial Cancer Hospital & Research Centre
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 30, 2024
- Completion date
- September 10, 2025
- Enrollment
- 124 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anxiety